-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Allarity Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2021 to Q1 2024.
- Allarity Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$1.49M, a 53.5% increase year-over-year.
- Allarity Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$12.7M, a 24.2% increase from 2022.
- Allarity Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$16.8M, a 13% decline from 2021.
- Allarity Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$14.9M, a 105% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)